ArticleScientific reports2026
Explainable federated transformer framework for joint leukemia classification and stage prediction.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Putting the I in AML: Artificial Intelligence and Machine Learning in Acute Myeloid Leukemia.Cells · 2026Review
- Recent advances in deep learning for leukemia diagnosis: a scoping review of diagnostic modalities and fusion-based approaches.Frontiers in digital health · 2026Review
- FedMal-XAI: an explainable federated vision transformer leveraging knowledge distillation for privacy-preserving malaria detection.Frontiers in public health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
The diagnosis of leukemia is based on the simultaneous analysis of morphological patterns of hematological images and the presence of clinical indicators in written reports. Majority of machine learning models are unimodal and centralized. They are not able to integrate information with the institutions or give clinically useful explanations. This paper suggests a federated multimodal architecture that integrates Vision Transformers (ViT) and ClinicalBERT to encode images and classify texts to conduct joint leukemia diagnosis and staging in decentralized medical devices, respectively. Both modalities are synthesised into a single semantic space to form a cross-modal fusion layer, and binary diagnosis and multiclass staging are facilitated by dual output heads. The framework uses federated learning protocol which maintains the privacy of data by the fact that the local data does not move out of institutional boundaries. To improve the level of transparency, SHAP-based explanations are provided on each prediction, where both visual regions and clinical tokens are considered important. The results of the experiments indicate that the suggested system is more accurate and has a higher F1-score than unimodal and centralized baselines and also has interpretable and patient-specific explanation, which is consistent with clinical expectations. The architecture is robust in the non-IID data distributions and is scaled through simulated healthcare networks, which makes it appropriate to deploy to actual health care in diagnostic oncology.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.